4//SEC Filing
Eizen Joshua M 4
Accession 0000950170-25-030042
CIK 0001880438other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:22 PM ET
Size
7.5 KB
Accession
0000950170-25-030042
Insider Transaction Report
Form 4
Eizen Joshua M
See Remarks
Transactions
- Award
Common Stock
2025-02-26+58,500→ 175,172 total - Award
Stock Option (right to buy)
2025-02-26+117,000→ 117,000 totalExercise: $1.13Exp: 2035-02-25→ Common Stock (117,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.
- [F2]Includes (a) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 (b) 22,500 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025 and (c) 45,000 RSUs which vest as follows: 2/3rd of the RSU vest on January 1, 2026 and 1/3rd of the RSUs vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date.
- [F3]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001949621
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:22 PM ET
- Size
- 7.5 KB